Semi-Annual Consolidated Statement Of Income

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7578452

Concept 2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
17,185,680,000 JPY
-814,049,000 JPY
16,371,630,000 JPY
12,180,000 JPY
492,131,000 JPY
16,020,119,000 JPY
15,515,808,000 JPY
1,165,560,000 JPY
12,946,186,000 JPY
12,695,000 JPY
414,099,000 JPY
13,402,957,000 JPY
12,406,433,000 JPY
12,833,228,000 JPY
-456,771,000 JPY
569,728,000 JPY
Cost of sales
7,724,851,000 JPY
5,924,777,000 JPY
Ordinary profit (loss)
6,880,181,000 JPY
4,684,099,000 JPY
Gross profit (loss)
8,646,779,000 JPY
7,021,408,000 JPY
Extraordinary income
45,731,000 JPY
1,419,800,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
4,862,913,000 JPY
3,720,904,000 JPY
Extraordinary losses
1,295,207,000 JPY
59,059,000 JPY
Profit (loss) before income taxes
5,630,706,000 JPY
6,044,840,000 JPY
Operating profit (loss)
3,883,585,000 JPY
-99,719,000 JPY
3,783,866,000 JPY
-518,377,000 JPY
-167,040,000 JPY
3,768,077,000 JPY
4,453,495,000 JPY
115,507,000 JPY
3,300,504,000 JPY
-496,500,000 JPY
11,068,000 JPY
3,351,231,000 JPY
3,854,351,000 JPY
3,368,919,000 JPY
-50,726,000 JPY
-17,688,000 JPY
Income taxes - current
700,305,000 JPY
703,623,000 JPY
Non-operating income
Interest income
16,698,000 JPY
5,217,000 JPY
Dividend income
1,000,000 JPY
500,000 JPY
Share of profit of entities accounted for using equity method
1,984,272,000 JPY
848,144,000 JPY
Non-operating income
3,355,625,000 JPY
1,483,464,000 JPY
Income taxes - deferred
575,547,000 JPY
85,824,000 JPY
Non-operating expenses
Interest expenses
90,500,000 JPY
98,411,000 JPY
Non-operating expenses
259,309,000 JPY
99,868,000 JPY
Income taxes
1,275,853,000 JPY
789,448,000 JPY
Extraordinary income
Gain on sale of non-current assets
11,438,000 JPY
796,000 JPY
Profit (loss)
4,354,853,000 JPY
5,255,391,000 JPY
Extraordinary losses
Impairment losses
620,000 JPY
8,981,000 JPY
Profit (loss) attributable to non-controlling interests
3,093,000 JPY
7,423,000 JPY
Profit (loss) attributable to owners of parent
4,351,759,000 JPY
5,247,968,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
5,596,229,000 JPY
-1,998,828,000 JPY
Foreign currency translation adjustment
1,111,262,000 JPY
329,082,000 JPY
Share of other comprehensive income of entities accounted for using equity method
112,398,000 JPY
48,102,000 JPY
Other comprehensive income
6,819,890,000 JPY
-1,621,643,000 JPY
Comprehensive income
11,174,743,000 JPY
3,633,748,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,175,939,000 JPY
3,627,503,000 JPY
Comprehensive income attributable to non-controlling interests
-1,196,000 JPY
6,244,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.